Target intelligence / Profile preview

High mobility group nucleosome binding domain 1 pseudogene 34[2][3] (HMGN1P34[2][3])

Target: HMGN1P34[2][3]
Molecular classification: Pseudogene[2][3][4][6]

Overview

High mobility group nucleosome binding domain 1 pseudogene 34 (HMGN1P34) is a human pseudogene derived from the high mobility group nucleosome binding domain 1 (HMGN1) gene family[2][3][4][6]. Pseudogenes are nonfunctional copies of genes that resemble their ancestral parent gene but have lost the ability to code for a productive protein, often due to mutations such as frameshifts or premature stop codons[4][6]. While some pseudogenes may be transcribed into RNA and participate in gene regulation by acting as sources of noncoding RNAs, microRNA decoys, or through RNA interference pathways, there is currently no evidence that HMGN1P34 has any such functional role. Pseudogenes like HMGN1P34 do not encode functional proteins, are not considered classic therapeutic targets, and are largely studied in the context of genomics and potential regulatory effects[1][4][6].

Other names: High-mobility group nucleosome binding domain 1 pseudogene 34[2]

Mechanism of action

None known; no drugs target this pseudogene.

Biological functions

No known protein-coding function[4][6]May act as a source of regulatory noncoding RNAs or influence regulation of related genes via RNA-based mechanisms (such as miRNA decoy, RNA interference, or transcriptional regulation), although this is speculative for the majority of pseudogenes and no specific evidence exists for HMGN1P34 itself[1][6]

Disease associations

None directly established.Some pseudogenes can play roles in cancer or genetic regulation via mechanisms detailed above, but there is no evidence for a disease role specific to HMGN1P34[1][6]

Safety considerations

None relevant, since it is not a protein or functional target for therapeutics.

Interacting drugs

None; this is a noncoding pseudogene and not a druggable target[4][6]

Biomarkers

None established for this pseudogene.

Beyond the preview

Go deeper on High mobility group nucleosome binding domain 1 pseudogene 34[2][3] (HMGN1P34[2][3]).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on High mobility group nucleosome binding domain 1 pseudogene 34[2][3] (HMGN1P34[2][3]).

Explore the full profile